A VACCINE COMPOSITION AND METHOD WHICH IS EFFECTIVE IN PREVENTING OR AMELIORATING AVIAN INFLUENZA VIRUS INFECTION IS SET FORTH HEREIN. THE VACCINE CONTAINS AT LEAST TWO INACTIVATED STRAINS OF AVIAN INFLUENZA VIRUS, WHEREIN THE COMBINED HAEMOAGGLUTININ (HA) TOTAL IS AT LEAST ABOUT 256 HA/DOSE OF THE VACCINE COMPOSITION, AND WHEREIN EACH OF THE STRAINS PRESENTS AT LEAST ABOUT 128 HA/DOSE, AND FURTHER WHEREIN ONE OF THE STRAINS HAS THE SAME HA SUBTYPE AS THAT OF A CHALLENGE VIRUS, AND WHEREIN AT LEAST ONE OF THE STRAINS HAS A DIFFERENT NA SUBTYPE THAN THE CHALLENGE VIRUS.